Andrew D. Jones Nova Bay Pharmaceuticals, Inc. (NBY) insider trading activity

NBY Quotes by TradingView

Andrew D. Jones is CFO of NovaBay Pharmaceuticals, Inc.. Currently has a direct ownership of 127,461 shares of NBY, which is worth approximately $75,201. The most recent transaction as insider was on Dec 06, 2021, when has been sold 36,765 shares (Common Stock) at a price of $0.44 per share, resulting in proceeds of $16,177. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K
0% 3M change
0% 12M change
Total Value Held $75,201

Andrew D. Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2021
BUY
Open market or private purchase
$16,177 $0.44 p/Share
36,765 Added 22.39%
127,461 Common Stock
Dec 03 2021
BUY
Open market or private purchase
$3,824 $0.44 p/Share
8,690 Added 8.74%
90,696 Common Stock
May 04 2021
SELL
Payment of exercise price or tax liability
$61,615 $0.79 p/Share
77,994 Reduced 48.75%
82,006 Common Stock

Also insider at

EYEN
EYENOVIA, INC. Healthcare
Chief Financial Officer
ADJ

Andrew D. Jones

CFO
Emeryville, CA

Track Institutional and Insider Activities on NBY

Follow NovaBay Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBY shares.

Notify only if

Insider Trading

Get notified when an Nova Bay Pharmaceuticals, Inc. insider buys or sells NBY shares.

Notify only if

News

Receive news related to NovaBay Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBY